Seattle, WA, United States of America

Christine C Siska


Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
6 patents (USPTO):

Title: **Innovator Spotlight: Christine C. Siska**

Introduction

Christine C. Siska, an accomplished inventor based in Seattle, WA, has made significant contributions to the field of ophthalmology through her innovative research and patented formulations. With a total of four patents to her name, Siska has carved a niche in the development of treatments aimed at eye disorders, showcasing her dedication to advancing medical science.

Latest Patents

Among her notable inventions are two recent patents focusing on aflibercept formulations. The first patent, titled "Aflibercept formulations containing a lysine salt as tonicifying agent and uses thereof," describes ophthalmic formulations suitable for treating eye disorders through intravitreal or topical administration. Additionally, her second patent, "Aflibercept formulations and uses thereof," further elaborates on pharmaceutical applications of aflibercept for eye treatments. These innovations demonstrate her commitment to improving patient care and treatment outcomes for those suffering from ophthalmic conditions.

Career Highlights

Throughout her career, Christine C. Siska has been associated with renowned organizations, including Just-evotec Biologics, Inc. and Beth Israel Deaconess Medical Center. Her work in these institutions has undoubtedly complemented her research endeavors and significantly contributed to her success as an inventor.

Collaborations

Siska has collaborated with talented individuals in her field, including colleagues Bruce A. Kerwin and Julee A. Floyd. These partnerships reflect her cooperative spirit and the importance of teamwork within the realm of scientific innovation and research.

Conclusion

Christine C. Siska's impressive portfolio of patents and her contributions to ophthalmology underline her status as a prominent figure in the medical innovation landscape. As she continues to advance her research, her work will undoubtedly leave a lasting impact on the treatment of eye disorders, further proving the value of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…